Acinic cell carcinoma epidemiology and demographics

Revision as of 13:32, 9 September 2019 by Ramyar (talk | contribs)
Jump to navigation Jump to search

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acinic cell carcinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acinic cell carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acinic cell carcinoma epidemiology and demographics

CDC on Acinic cell carcinoma epidemiology and demographics

Acinic cell carcinoma epidemiology and demographics in the news

Blogs on Acinic cell carcinoma epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Acinic cell carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Acinic cell carcinoma can appear at any age however, it is common in children.

  • Acinic cell carcinoma appears in all age groups, but presents at a younger median age (approximately 52 years) than most other salivary gland cancers.
  • Women are more frequently diagnosed than men.
  • Occurrences in children are quite common.
  • According to the National Cancer Data Base Report on cancer of the head and neck in the United States, the parotid gland was the predominant site of origin (86.3%) for reported acinic cell carcinoma.
  • Regional and distant metastasis, high grade, and large tumor size were all more common among patients older than 30.
  • No ethnic or racial predilection showed an association with acinic cell carcinoma.

Epidemiology and Demographics

Incidence

Prevalence

  • In western countries, salivary gland carcinomas account for 4000 out of 100000 of all head and neck carcinomas, and approximately 80% of those occurring in parotid gland.[1][2]
  • one out of six parotid gland cancer is acinic cell carcinoma.

Case-fatality rate/Mortality rate

Age

  • Disturbution of acinic cell carcinoma between age groups seems to be quiet even, with a median age of 52 years, but it occurs mostly at a younger age.[3]
  • Children are rarely affected with salivary gland carcinoma, but if they are , it is most likely to be acinic cell carcinoma.[4]

Race

  • Acinic cell carcinoma is predominantly seen in in whites (85000 out of 100000 cases) and less in African nations(8000 out of 100000 cases)[5]

Gender

  • There is a higher incidence among female with the ratio ranging from 1.43:1 to 1.57:1.[6]

Region

Developed Countries

Developing Countries

References

  1. Vander Poorten, V.; Triantafyllou, A.; Thompson, L. D. R.; Bishop, J.; Hauben, E.; Hunt, J.; Skalova, A.; Stenman, G.; Takes, R. P.; Gnepp, D. R.; Hellquist, H.; Wenig, B.; Bell, D.; Rinaldo, A.; Ferlito, A. (2015). "Salivary acinic cell carcinoma: reappraisal and update". European Archives of Oto-Rhino-Laryngology. 273 (11): 3511–3531. doi:10.1007/s00405-015-3855-7. ISSN 0937-4477.
  2. Al-Mamgani, Abrahim; van Rooij, Peter; Verduijn, Gerda M.; Meeuwis, Cees A.; Levendag, Peter C. (2012). "Long-term Outcomes and Quality of Life of 186 Patients With Primary Parotid Carcinoma Treated With Surgery and Radiotherapy at the Daniel den Hoed Cancer Center". International Journal of Radiation Oncology*Biology*Physics. 84 (1): 189–195. doi:10.1016/j.ijrobp.2011.11.045. ISSN 0360-3016.
  3. Neskey, David M.; Klein, Jonah D.; Hicks, Stephanie; Garden, Adam S.; Bell, Diana M.; El-Naggar, Adel K.; Kies, Merrill S.; Weber, Randal S.; Kupferman, Michael E. (2013). "Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma". JAMA Otolaryngology–Head & Neck Surgery. 139 (11): 1195. doi:10.1001/jamaoto.2013.4728. ISSN 2168-6181.
  4. Khosravi, Mohammad Hossein; Bagherihagh, Ali; Saeedi, Masoumeh; Dabirmoghaddam, Payman; Kouhi, Ali; Amirzade-Iranaq, Mohammad Hosein (2017). "Salivary Gland Cancers: A Survey through History, Classifications and Managements". doi:10.5772/intechopen.70127.
  5. Gomez, Daniel R.; Katabi, Nora; Zhung, Joanne; Wolden, Suzanne L.; Zelefsky, Michael J.; Kraus, Dennis H.; Shah, Jatin P.; Wong, Richard J.; Ghossein, Ronald A.; Lee, Nancy Y. (2009). "Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland". Cancer. 115 (10): 2128–2137. doi:10.1002/cncr.24259. ISSN 0008-543X.
  6. Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR (1999). "National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma". Head Neck. 21 (4): 297–309. PMID 10376748.

Template:WH Template:WS